Mepolizumab decreases exacerbations in patients with eosinophilic COPD
1. In this randomized controlled trial, mepolizumab decreased the annualized rate of moderate or severe exacerbations when added to triple ...
Tag: Mepolizumab
Benralizumab noninferior to mepolizumab for eosinophilic granulomatosis with polyangiitis
1. In this randomized controlled trial, benralizumab was noninferior for beginning remission in patients with eosinophilic granulomatosis with polyangiitis (EGPA) ...
Mepolizumab reduced exacerbations in children with exacerbation-prone eosinophilic asthma
1. There was a 27% reduction of severe asthma exacerbations in children treated with mepolizumab compared to control. 2. There ...
2 Minute Medicine Rewind September 18, 2017
Research and Development Spending to Bring a Single Cancer Drug to Market and Revenues After Approval There is current debate ...
![Mepolizumab reduces exacerbations in severe eosinophilic asthma [MENSA trial]](https://www.2minutemedicine.com/wp-content/uploads/2014/09/800px-Inhaler-350x250.jpg)
Mepolizumab reduces exacerbations in severe eosinophilic asthma [MENSA trial]
1. The rate of asthma exacerbations was significantly reduced in patients with severe eosphinophilic asthma receiving either intravenous or subcutaneous ...